SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
robert f. kennedy jr
Watchdogs Renew Warnings of 'Profoundly Unqualified' Dr. Oz After Senate Hearing
"Between his massive conflicts of interest across the healthcare sector and his endorsement of further privatizing Medicare, Oz would be a threat to the health of tens of millions of Americans," said one opponent.
Mar 14, 2025
Progressive watchdog organizations responded to the U.S. Senate Finance Committee's Friday hearing for Dr. Mehmet Oz by again sounding the alarm about the heart surgeon and former television host nominated to lead a key federal healthcare agency.
Since President Donald Trumpannounced Oz as his nominee for administrator of the Centers for Medicare and Medicaid Services (CMS) last November, opponents have spotlighted the doctor's promotion of unproven products, investments in companies with interests in the federal agency, and support for expanding Medicare Advantage during an unsuccessful U.S. Senate run in 2022.
"Dr. Oz's career promoting dubious medical treatments and pseudoscience often for personal financial gain should immediately disqualify him from serving in any public health capacity, let alone in a top administration health post," Accountable.US executive director Tony Carrk said in a Friday statement.
"Dr. Oz's nomination is part of President Trump's grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections."
In December, Carrk's group found that based on disclosures from Oz's 2022 run against U.S. Sen. John Fetterman (D-Pa.), the Republican doctor reported "up to $56 million in investments in three companies" with direct CMS interests—including Sharecare, which became the "exclusive in-home care supplemental benefit program" for 1.5 million Medicare Advantage enrollees.
A spokesperson said at the time that Oz has since divested from Sharecare. However, critics have still expressed concern about how the nominee's confirmation could boost Republican efforts to expand Medicare Advantage—health insurance plans for seniors administered by private companies rather than the government.
"As a self-interested advocate of privatizing Medicare at a higher cost and more denials of care for seniors, Dr. Oz is surely eager to enact the Trump-Republican budget plan to gut Medicare and Medicaid and jeopardize health coverage for millions of Americans—all to pay for more tax breaks for billionaires and price gouging corporations," said Carrk. "Dr. Oz's nomination is part of President Trump's grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections—especially those with preexisting conditions."
As he faces Senate confirmation, remember that Dr. Oz: -Pushed Medicare privatization plans on his show -Owns ~$600k in stock in private insurers -Has ties to pyramid scheme companies that promote fake medical cures His main qualification to oversee CMS is loyalty to Trump.
— Robert Reich ( @rbreich.bsky.social) March 14, 2025 at 1:41 PM
Robert Weissman, co-president of the consumer advocacy group Public Citizen, has been similarly critical of Oz, and remained so after senators questioned him on Friday, saying in a statement that "Mehmet Oz showed he is profoundly unqualified to lead any part of our healthcare system, let alone an agency as important as CMS."
"Between his massive conflicts of interest across the healthcare sector and his endorsement of further privatizing Medicare, Oz would be a threat to the health of tens of millions of Americans," Weissman warned. "Privatized Medicare Advantage plans deliver inferior care and cost taxpayers nearly $100 billion annually in excess costs."
"It is time for President Trump to put down the remote, stop finding nominees on television, and instead nominate people with actual experience and a belief in the importance of protecting crucial health programs like Medicare and Medicaid," he argued, taking aim at not only the president but also his billionaire adviser Elon Musk, head of the so-called Department of Government Efficiency(DOGE) and, Robert F. Kennedy Jr., the conspiracy theorist now running the Department of Health and Human Services.
Weissman declared that "Trump, Musk, and RFK Jr. fail to put the American people first as they seek to gut agencies and make dangerous cuts to health programs to fund tax cuts for billionaires. Oz indicated he would not oppose such cuts, bringing more destruction to lifesaving programs. Oz has no place in government and should be roundly rejected by every senator."
During a Friday exchange with Sen. Ron Wyden (D-Ore.), the committee's ranking member, Oz refused to decisively commit to opposing cuts to Medicaid. As the Alliance for Retired Americans highlighted, Oz kept that up when given opportunities to revise his answer by Sens. Ben Ray Luján (D-N.M.) and Michael Bennet (D-Colo.).
Other moments from the hearing that garnered attention included Oz's exchange with Sen. Catherine Cortez Masto (D-Nev.) about Affordable Care Act tax credits and Sen. Maggie Hassan (D-N.H.) calling out the doctor for his unwillingness "to take accountability for" his "promotion of unproven snake oil remedies" to millions of TV viewers.
Keep ReadingShow Less
RFK Jr. Will Need a Miracle Cure to Fight Cancer on Trump’s Budget
At the same time Trump is pledging to reverse childhood cancer rates, he and his attack doge Elon Musk are gutting federal health agencies to help pay for huge tax breaks for corporations and the uber rich.
Mar 11, 2025
During his marathon, fact-free speech to Congress last week, President Donald Trump announced that his administration plans to address the growing incidence of childhood cancer.
“Since 1975, rates of child cancer have increased by more than 40%,” Trump said. “Reversing this trend is one of the top priorities for our new presidential commission to make America healthy again, chaired by our new Secretary of Health and Human Services Robert F. Kennedy Jr. …Our goal is to get toxins out of our environment, poisons out of our food supply, and keep our children healthy and strong.”
As usual, Trump got the statistic wrong. In fact, childhood cancer rates increased 33% since 1975, according to a study published in the journal PLOS One in January (and verified by the American Cancer Society), and the uptick in cases can be at least partly attributed to improved detection technology.
What would a major loss of federal scientific expertise mean for HHS Secretary Kennedy’s childhood cancer commission? Given that Kennedy, a prominent anti-vaccine activist, is not known for paying attention to scientific evidence, it may not matter much.
That said, the PLOS One study did find that some childhood cancers—notably leukemia, lymphoma, brain tumors, liver tumors, and gonadal tumors—are on the rise, so by all means, the federal government should do more to try to reduce them.
But at the same time Trump is pledging to reverse childhood cancer rates and “get toxins out of our environment,” he and his attack doge Elon Musk are gutting federal health agencies to help pay for huge tax breaks for corporations and the uber rich.
Indiscriminate Cuts Across the Board
All of the agencies that protect public health are on the chopping block.
Just a few weeks ago, for example, his administration illegally fired some 5,200 employees at Kennedy’s Department of Health and Human Services (HHS), including nearly 1,300 staff members at the Centers for Disease Control and Prevention (CDC), roughly a tenth of the agency’s workforce.
Meanwhile, over at the Environmental Protection Agency (EPA), the new administrator, Lee Zeldin, is threatening a budget cut of at least 65%. That would leave the agency with an annual budget of about $3.2 billion, less than a third of its budget in fiscal year (FY) 1970—the year it began—in inflation-adjusted 2024 dollars. Such a meager budget would destroy the agency, exactly what the fossil fuel industry-funded Republican Party has been wanting to do for years.
The Trump administration is also trying to ax a key portion of National Institutes of Health (NIH) biomedical research funding, which would undermine any effort to curtail childhood cancer—not to mention research on other deadly diseases.
On February 7, it announced it will cut an estimated $4 billion from NIH grants by capping funding for “indirect” overhead costs that cover such expenses as facilities, electric utilities, and administrative and janitorial services at 15%, half the current average rate. About $26 billion of NIH’s $35 billion in FY2023 grants that went to more than 2,500 universities, medical schools, and other research institutions covered direct costs—researchers and laboratories. The balance—$9 billion—paid for overhead.
Experts warn that without adequate overhead support, researchers would not be able to do their work.
Three days after the administration announced its intention to cut the NIH budget, five medical associations and 22 states filed lawsuits challenging the plan. Later that day, U.S. District Judge Angel Kelley in Boston granted a temporary restraining order. She followed up on March 5, the day after Trump’s speech to Congress, by filing a preliminary injunction that put the cuts on hold while the lawsuits proceed. “The risk of harm to research institutions and beyond,” Kelley wrote in a 76-page order, “is immediate, devastating, and irreparable.”
It’s 2017 all Over Again (With a Major Difference)
Trump’s zeal to hobble federal medical and scientific research should not come as a surprise. To a great extent, his current budget-chopping campaign reflects the FY2018 budget he proposed in May 2017. That radical proposal called for shrinking the budgets of NIH by 18%; EPA by 31%, the Food and Drug Administration by 31%, and the CDC by 17%, which would have been its lowest budget since 1997. It also called for hacking $610 billion from Medicaid over the following decade on top of an $880-billion cut a Republican healthcare plan advocated.
That budget was dead on arrival, despite the fact that Republicans controlled the White House, the House, and the Senate, albeit by only a 51 to 49 margin. Oklahoma Republican Tom Cole, then-chair of the House spending subcommittee that funds NIH, toldScientific American that he did not expect Congress to support Trump’s proposed cuts. Other legislators from both sides of the aisle also rejected the president’s NIH budget proposal. (Nevertheless, Trump’s previous administration did a lot of damage by eliminating or weakening over 100 environmental safeguards.)
Today, Republicans have the White House and slim majorities in both houses of Congress. Unlike 2017, however, congressional Republicans are in lockstep with Trump, and thus far have been cheering him and Musk on from the sidelines as they dismantle the federal government.
What would a major loss of federal scientific expertise mean for HHS Secretary Kennedy’s childhood cancer commission? Given that Kennedy, a prominent anti-vaccine activist, is not known for paying attention to scientific evidence, it may not matter much. It’s been widely reported that Kennedy has been telling children and adults in Texas to try Vitamin A, cod liver oil, and other dubious treatments if they get measles instead of urging them to get vaccinated, so one could only imagine what he would recommend that parents give their children to protect them from cancer. Aloe? Emu oil? Kombucha? All of the above?
This column was originally posted on Money Trail, a new Substack site co-founded by Elliott Negin.
Keep ReadingShow Less
Senators Want to Know Why RFK Jr. Dined With Pharma Execs at Trump's Private Club
"You owe the American public an explanation for why you took part in PhRMA's influence-peddling events with President Trump," wrote Sens. Elizabeth Warren, Ron Wyden, and Bernie Sanders.
Mar 11, 2025
A group of progressive U.S. senators on Monday pushed Robert F. Kennedy Jr., secretary of the Health and Human Services Department, to disclose what he and President Donald Trump discussed with pharmaceutical executives at recent private dinners as the industry pressures the new administration to end Medicare drug price negotiations.
In a letter to Kennedy, Sens. Elizabeth Warren (D-Mass.), Ron Wyden (D-Ore.), and Bernie Sanders (I-Vt.) pointed to Wall Street Journalreporting from last month on the millions of dollars that healthcare industry executives spent to dine with Trump at his Mar-a-Lago club in Florida ahead of his inauguration.
Kennedy, according to the Journal, "attended several of the dinners, but largely stayed quiet as Trump and others talked."
Warren, Wyden, and Sanders wrote to Kennedy that "the dinners may have served as an opportunity for Big Pharma to gain insider access to both you and President Trump" and asked the HHS chief to reveal information about the meetings with industry executives, including how many there have been since the November election and whether Medicare drug price negotiations or other critical matters were discussed.
"Big Pharma stands to profit immensely from a second Trump administration, especially if they can convince you and President Trump to abandon policies like Medicare drug price negotiations and patent reform that would save Americans hundreds of billions of dollars on lifesaving drugs," the senators wrote. "Indeed, the executives that attended these dinners have called on him to 'pause drug negotiations'—negotiations that are expected to save taxpayers $100 billion by 2032."
"You owe the American public an explanation for why you took part in PhRMA's influence-peddling events with President Trump, what happened at these meetings, and whether they will affect your commitment to ensuring that Americans receive the relief they deserve from high drug prices," the senators added.
RFK Jr. said he'd "clean up corruption" as HHS Secretary. So why'd he have dinner with Big Pharma executives at Mar-a-Lago with Trump? The American people deserve to know what kind of deals might have been made at those "million-dollar" dinners.
[image or embed]
— Elizabeth Warren (@warren.senate.gov) March 10, 2025 at 7:29 PM
The Journal reported that the CEO of Pfizer, which pumped $1 million into Trump's inaugural committee, was among the executives who attended the private Mar-a-Lago dinners. Eli Lilly's chief executive also joined at least one of the dinners.
Though Kennedy, an anti-vaccine conspiracy theorist, has vocally criticized Big Pharma and its political influence, the industry did not lobby against his nomination to lead HHS, which oversees the Medicare drug price negotiations that began during the Biden administration.
Last month, the head of the pharmaceutical industry's biggest lobbying group and several pharma CEOs met with Trump as part of a campaign to weaken the price negotiations, which threaten drugmakers' ability to jack up prices at will.
The negotiations have yielded significant results, but Trump's Centers for Medicare and Medicaid Services—an agency within HHS—has signaled it is open to altering the program.
"The Trump administration's statement is far from an embrace of drug price negotiation," Wyden and other senators warned earlier this year, "and appears to be opening the door to changes that could undermine Medicare's ability to get the best price possible on drugs."
Keep ReadingShow Less
Most Popular